About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 193 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 193 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 193 trials

CompletedComparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With SchizophreniaKey objectives of this clinical study are to: * Determine how well intramuscular (IM) olanzapine depot works compared to placebo * Evaluate the safety and tolerability of IM…NCT00088478·National City, California and 36 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedStudy to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaStudy to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia.NCT05182476·Phoenix, Arizona and 48 others

CompletedDexmedetomidine in the Treatment of Agitation Associated With SchizophreniaThis is a definitive study to support the safety and efficacy evaluation of BXCL501 for the acute treatment of agitation in schizophrenia.NCT04268303·Little Rock, Arkansas and 14 others

CompletedStudy of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyThe purpose of this study is to determine if EVP-6124 (an alpha-7 nAChR agonist) enhances the cognitive abilities of subjects with Schizophrenia who are also taking stable…NCT01714661·Tucson, Arizona and 93 others

CompletedA Study of ALKS 3831 in Adults With SchizophreniaThis is a Phase 2, randomized, placebo-controlled multicenter study, which will be conducted in 2 parts.NCT01903837·Little Rock, Arkansas and 60 others

CompletedEffect of MMFS-202-302 on Cognitive Enhancement in SchizophreniaThe goals of this study are to study MMFS-202-302 in a double blind, randomized, placebo-controlled 9-week study of its effect on ameliorating cognitive deficits in 60 patients…NCT02237235·Chicago, Illinois

CompletedA 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyThis study is being conducted to further investigate the safety of prolonged exposure to EVP-6124 in subjects with Schizophrenia receiving a stable dose of an atypical…NCT01714713·Little Rock, Arkansas and 127 others

CompletedProof of Concept Study of Cognitive Improvement in Patients With SchizophreniaThe purpose of this study is to demonstrate that AZD3480 improves cognition in patients with stable schizophrenia who are being treated with an atypical antipsychotic and who are…NCT00528905·Little Rock, Arkansas and 79 others

RecruitingSafety and Efficacy of Brilaroxazine (RP5063) in SchizophreniaThis study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term.NCT05184335·Phoenix, Arizona and 17 others

CompletedAn Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With SchizophreniaThe primary objective of this study was to continue to provide aripiprazole intramuscular (IM) depot treatment (400 milligrams \[mg\] or 300 mg) to participants with schizophrenia…NCT01129882·Bellevue, California and 156 others

CompletedA Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With SchizophreniaA clinical trial to study the efficacy and safety of an investigational drug in acutely psychotic people with schizophrenia.NCT04092686·Rogers, Arkansas and 52 others

CompletedOpen Label Extension Study of BifeprunoxA one year extension study using flexible doses, 20 or 30 mg daily, of open-label bifeprunox.NCT00366171·Little Rock, Arkansas and 82 others

CompletedA Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)This study will evaluate weight gain of ALKS 3831 compared to olanzapine in adult subjects with schizophrenia.NCT02694328·Little Rock, Arkansas and 53 others

Completed15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedThe study will assess the use of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to a protocol-defined treatment failure over 15 months, in…NCT01157351·Bullhead City, Arizona and 55 others

Active not recruitingReal-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT UsersThis study uses existing health records and insurance claims data to understand how adults in the United States are treated with KarXT, a medication for schizophrenia.NCT07571148·Chicago, Illinois

CompletedA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaML-007C-MA-211 is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of orally administered ML-007C-MA in inpatient…NCT07038876·Little Rock, Arkansas and 23 others

TerminatedExtension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaTo evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophreniaNCT03121586·Phoenix, Arizona and 160 others

CompletedA Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.The objective of the study is to investigate the efficacy, safety and tolerability of four different doses of BI 409306 once daily compared to placebo given for 12 weeks in…NCT02281773·Little Rock, Arkansas and 42 others

TerminatedTreatment of Depression With QuetiapineThe purpose of this study is to examine the mood stabilizing and antipsychotic properties of quetiapine in the treatment of depression by comparing subjects who were randomly…NCT00174603·Chicago, Illinois

CompletedPharmacodynamic/Pharmacokinetic Study of AQW051 in SchizophreniaPart 1 of the study will assess the enhancement of task-related brain activation (BOLD response) in key brain areas in schizophrenia during the performance of working memory…NCT00825539·Los Angeles, California and 6 others

Page 1 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia